NDC 13668-329

Amlodipine, Valsartan and Hydrochlorothiazide

Amlodipine, Valsartan And Hydrochlorothiazide

Amlodipine, Valsartan and Hydrochlorothiazide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Torrent Pharmaceuticals Limited. The primary component is Amlodipine Besylate; Valsartan; Hydrochlorothiazide.

Product ID13668-329_058f3b5a-a1d4-4c33-88e5-a24601d77997
NDC13668-329
Product TypeHuman Prescription Drug
Proprietary NameAmlodipine, Valsartan and Hydrochlorothiazide
Generic NameAmlodipine, Valsartan And Hydrochlorothiazide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-06-03
Marketing CategoryANDA / ANDA
Application NumberANDA201593
Labeler NameTorrent Pharmaceuticals Limited
Substance NameAMLODIPINE BESYLATE; VALSARTAN; HYDROCHLOROTHIAZIDE
Active Ingredient Strength5 mg/1; mg/1; mg/1
Pharm ClassesCalcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 13668-329-05

500 TABLET in 1 BOTTLE (13668-329-05)
Marketing Start Date2015-06-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 13668-329-74 [13668032974]

Amlodipine, Valsartan and Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA201593
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-06-03
Marketing End Date2020-01-31

NDC 13668-329-30 [13668032930]

Amlodipine, Valsartan and Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA201593
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-06-03
Marketing End Date2020-01-31

NDC 13668-329-01 [13668032901]

Amlodipine, Valsartan and Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA201593
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-06-03
Marketing End Date2020-01-31

NDC 13668-329-05 [13668032905]

Amlodipine, Valsartan and Hydrochlorothiazide TABLET
Marketing CategoryANDA
Application NumberANDA201593
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-06-03
Marketing End Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
AMLODIPINE BESYLATE5 mg/1

OpenFDA Data

SPL SET ID:2e1d5c9d-f161-45ef-a2b0-702567139dc3
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 848151
  • 848145
  • 848131
  • 848140
  • 848135
    • UPC Code
  • 0313668325058
  • 0313668328059
  • 0313668327052
  • 0313668329056
  • 0313668326055

    • Pharmacological Class

    • Calcium Channel Antagonists [MoA]
    • Dihydropyridine Calcium Channel Blocker [EPC]
    • Dihydropyridines [CS]
    • Angiotensin 2 Receptor Antagonists [MoA]
    • Angiotensin 2 Receptor Blocker [EPC]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]

    Medicade Reported Pricing

    13668032930 AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Amlodipine, Valsartan and Hydrochlorothiazide" or generic name "Amlodipine, Valsartan And Hydrochlorothiazide"

    NDCBrand NameGeneric Name
    13668-325Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    13668-326Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    13668-327Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    13668-328Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    13668-329Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    57297-771Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    57297-772Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    57297-773Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    57297-774Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    57297-775Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    65862-834Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    65862-835Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    65862-836Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    65862-837Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    65862-838Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    68180-771Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    68180-772Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    68180-773Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    68180-775Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    68180-774Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    70518-1220Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and Hydrochlorothiazide
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.